Pretreatment Serum Levels of IL-1 Receptor Antagonist and IL-4 Are Predictors of Overall Survival in Multiple Myeloma Patients Treated with Bortezomib

Multiple myeloma (MM) is characterized by the malignant proliferation of monoclonal plasma cells in the bone marrow with an elevation in monoclonal paraprotein, renal impairment, hypercalcemia, lytic bony lesions, and anemia. Immune cells and associated cytokines play a significant role in MM growth...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikulski, Damian, Robak, Paweł, Perdas, Ewelina, Węgłowska, Edyta, Łosiewicz, Aleksandra, Dróżdż, Izabela, Jarych, Dariusz, Misiewicz, Małgorzata, Szemraj, Janusz, Fendler, Wojciech, Robak, Tadeusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745099/
https://www.ncbi.nlm.nih.gov/pubmed/35011853
http://dx.doi.org/10.3390/jcm11010112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745099/
https://www.ncbi.nlm.nih.gov/pubmed/35011853
http://dx.doi.org/10.3390/jcm11010112

Ejemplares similares